ABPA

Questions discussed in this category

Is there a role for biologics to help patients with ABPA who are steroid responsive and have removed their allergen insult, but continue to have an elevated serum IgE and incomplete resolution of symptoms return to their baseline functional status?

1 Answer available

Do you consider dual biologic therapy in patients with ABPA that remain steroid dependent despite the use of omalizumab?

2 Answers available

Is there a role for the use of biologics as steroid sparing agents in treating patients with ABPA who are intolerant to prednisone?

1 Answer available

Papers discussed in this category

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000-04

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Chest, 2018 Jan 11

A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary Aspergillosis Complicating Asthma.

J Allergy Clin Immunol Pract, 2021 Mar 06

Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization.

Chest, 2020 Aug 31

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.

J Allergy Clin Immunol Pract, 2020 Jun 16

Omalizumab Is an Effective Intervention in Severe Asthma with Fungal Sensitization.

Cureus, 2020 Aug 12

Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases.

J Allergy Clin Immunol Pract, 2015 Jan 29

Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.

Related Topics